ABCL

Q: What is the price of AbCellera Biologics (ABCL) today?

The price of AbCellera Biologics (ABCL) today is R$ 23,69, with a variation of 62.45% compared to the last year. The price of AbCellera Biologics (ABCL) started the year trading around R$ 15,88 and today it is at R$ 23,69. Follow the real-time price chart, the historical price of AbCellera Biologics (ABCL), and stock data from Ibovespa and international markets.

Q: When does AbCellera Biologics (ABCL) pay dividends?

AbCellera Biologics (ABCL) did not distribute dividends in the last year.

Q: AbCellera Biologics (ABCL) is it worth it?

Currently, AbCellera Biologics (ABCL) is priced at R$ 23,69, with a P/E of -7,92%, representing a deviation of 3,96% from its historical average P/E. In the last year, the stock showed a variation of 62.45% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 62,45%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of AbCellera Biologics (ABCL)?

Investing in shares of AbCellera Biologics (ABCL) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of AbCellera Biologics (ABCL) yield today?

The yield of AbCellera Biologics (ABCL) was -14,48% in the last month, 62,45% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of AbCellera Biologics (ABCL) today, the total investment would be based on the current price of R$ 23,69.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 3.847,69In 5 years: R$ 2.368,54In 10 years: 2.368,54It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

AbCellera Biologics Inc.

Price

US$ 4,37

variation (12m)

62,45%

p/l

-7,92

p/vp

1,30

DIVIDEND YIELD

0,00%

quote ABCL

BVMF

ABCL

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of ABCL

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-14,48%

3 months

114,22%

1 year

62,45%

2 years

-20,69%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

-14,48%

3 months

113,15%

1 year

54,35%

2 years

-27,71%

5 years

0,00%

10 years

0,00%

Indicators ABCL

check out the fundamentals of AbCellera Biologics shares

P/L

-7,92

Sector: -1,52 Industry: -3,80

P/SALES (PSR)

39,92

Sector: 1,99 Industry: 2,90

P/VP

1,30

Sector: 2,16 Industry: 1,76

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

-11,82%

Sector: -26,53% Industry: -56,94%

ROE

-16,45%

Sector: -31,21% Industry: -45,34%

ROIC

-23,29%

Sector: -404,40% Industry: -420,46%

Net Margin

-100,00%

Sector: -26,56% Industry: -32,35%

GROSS MARGIN

100,00%

Sector: 44,49% Industry: 44,86%

OPERATING MARGIN

-100,00%

Sector: -23,10% Industry: -30,21%

P/EBITDA

-6,63

Sector: 0,07 Industry: -2,60

P/EBIT

-4,98

Sector: -1,37 Industry: -3,22

P/ASSETS

0,94

Sector: 1,23 Industry: 1,32

VPA

3,37

Sector: 3,66 Industry: 1,68

LPA

-0,55

Sector: -0,80 Industry: -1,22

EQUITY / ASSETS

0,72

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

-32,41%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

0,00%

Sector: - Industry: -

ABCL indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
LLY	45,25	34,03	75,21%	0,81%	US$ 624,41 B	25,91%
ISRG	65,56	9,52	14,52%	0,00%	US$ 170,94 B	28,51%
TMO	28,71	3,73	13,01%	0,33%	US$ 189,00 B	15,24%
MDT	25,50	0,00	0,00%	3,03%	US$ 118,85 B	13,63%
SNY	11,17	1,55	13,90%	4,31%	US$ 125,86 B	14,83%
CVS	19,92	1,16	5,84%	3,73%	US$ 90,27 B	1,17%
GSK	17,94	4,15	23,12%	4,04%	US$ 80,77 B	10,87%
ABT	15,66	4,31	27,50%	1,81%	US$ 218,97 B	32,43%
NVS	18,12	5,88	32,47%	3,05%	US$ 247,36 B	24,74%
TMDX	56,86	12,81	22,53%	0,00%	US$ 4,07 B	13,49%
HCA	16,35	-78,84	-482,31%	0,68%	US$ 97,60 B	8,21%
BSX	62,73	6,94	11,06%	0,00%	US$ 157,13 B	13,54%
INMD	5,22	1,48	28,44%	0,00%	US$ 933,03 M	44,50%
DHR	44,49	2,90	6,52%	0,56%	US$ 151,86 B	14,21%
IDXX	52,40	35,40	67,57%	0,00%	US$ 51,64 B	24,41%
FMS	20,59	0,91	4,42%	3,07%	US$ 15,03 B	3,41%
HUM	23,00	1,98	8,61%	1,18%	US$ 36,24 B	1,28%
PHG	127,59	2,23	1,75%	3,13%	US$ 26,81 B	1,07%
DXCM	56,42	12,53	22,21%	0,00%	US$ 32,25 B	13,29%

comparison of ABCL with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history ABCL dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY AbCellera Biologics

AbCellera Biologics Inc.

Average user rating I10

4.0 (2 people)

Estados Unidos

13 years

Foundation: 2012

2020

Year of debut on the stock exchange - 5 years

206

Employees

The Company AbCellera Biologics Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 1,31 Billion, having a net worth of $ 1,01 Billion.

With a total of 206 employees, the company is listed in the sector of Saúde and categorized in industry of Ferramentas e Serviços de Ciências da Vida.

In the last 12 months the Company had a revenue of $ 32,88 Milhões, which generated a loss in the amount of $ -165,67 Milhões.

As for its main indicators, the Company has a P/E ratio of -7,92, a P/B ratio of 1,30 and in the last 12 months the Company did not pay dividends.

The Company is traded through the ticker ABCL.

Market value

US$ 1,31 Billion

Net worth

US$ 1,01 Billion

US$ 1.007.080.000,00

Assets

US$ 1,40 Billion

US$ 1.402.060.000,00

Total Number of Shares

299,00 Milhões

299.000.000

Average Daily Trading Volume

US$ 6,59 Milhões

US$ 6.585.635,52

Sector

Saúde

Industry

Ferramentas e Serviços de Ciências da Vida

ABCL

ABCL revenue and profits

ABCL results

DRAG THE FRAME TO SEE MORE DATA

ABCL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12 M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12 M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12 M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12 M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12 M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12 M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12 M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

Common Questions

What is the price of AbCellera Biologics (ABCL) today?

The price of AbCellera Biologics (ABCL) today is R$ 23,69, with a variation of 62.45% compared to the last year. The price of AbCellera Biologics (ABCL) started the year trading around R$ 15,88 and today it is at R$ 23,69. Follow the real-time price chart, the historical price of AbCellera Biologics (ABCL), and stock data from Ibovespa and international markets.

When does AbCellera Biologics (ABCL) pay dividends?

AbCellera Biologics (ABCL) did not distribute dividends in the last year.

AbCellera Biologics (ABCL) is it worth it?

Currently, AbCellera Biologics (ABCL) is priced at R$ 23,69, with a P/E of -7,92%, representing a deviation of 3,96% from its historical average P/E. In the last year, the stock showed a variation of 62.45% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 62,45%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of AbCellera Biologics (ABCL)?

Investing in shares of AbCellera Biologics (ABCL) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of AbCellera Biologics (ABCL) yield today?

The yield of AbCellera Biologics (ABCL) was -14,48% in the last month, 62,45% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of AbCellera Biologics (ABCL) today, the total investment would be based on the current price of R$ 23,69.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 3.847,69
In 5 years: R$ 2.368,54
In 10 years: 2.368,54

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

ABCL

AbCellera Biologics Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of ABCL

check out the fundamentals of AbCellera Biologics shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY AbCellera Biologics

AbCellera Biologics Inc.

Estados Unidos

13 years

2020

206

PROFIT X PRICE ABCL

ABCL results

ABCL cash flow

evolution of assets - ABCL

ABCL balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80